Actively Recruiting
A Pilot Study of Transcranial Magnetic Stimulation Plus Episodic Future Thinking for Methamphetamine Use Disorder
Led by The University of Texas Health Science Center, Houston · Updated on 2026-03-05
20
Participants Needed
1
Research Sites
92 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to assess impact of repetitive transcranial magnetic stimulation (rTMS)+Episodic Future Thinking (EFT) vs. sham rTMS+EFT on delay discounting and methamphetamine (MA) demand, on vividness of future positive events during EFT training and on frequency of episodic thinking during the week following EFT training
CONDITIONS
Official Title
A Pilot Study of Transcranial Magnetic Stimulation Plus Episodic Future Thinking for Methamphetamine Use Disorder
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Meet DSM-5 criteria for primary methamphetamine use disorder
- Be fluent in English and able to understand the consent form
You will not qualify if you...
- Current DSM-5 diagnosis for any illicit substance use disorder other than methamphetamine and marijuana
- Current DSM-5 diagnosis of moderate or greater severity for alcohol and marijuana use disorder
- Any medical, neurological, psychiatric, or physical condition that may interfere with study completion or safety
- Current or recent suicidal or homicidal ideation or behavior based on specific assessments
- Medical implants contraindicating TMS within 30 cm of the coil
- History of brain surgery
- History of intracranial lesion or conditions causing increased intracranial pressure, or recent severe headaches or vision loss
- Moderate-to-severe heart disease
- History of stroke
- Use of certain medications increasing seizure risk or unsafe doses of antidepressants/antipsychotics
- Personal or family history of epilepsy or seizures
- Serious head injury with loss of consciousness
- Impending incarceration
- Pregnant or nursing females
- Inability to read, write, or speak English
- For ages 18-21: any risk factor for neurocardiogenic syncope
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The University of Texas Health Science Center at Houston
Houston, Texas, United States, 77030
Actively Recruiting
Research Team
H
Heather Webber, PhD
CONTACT
J
Jessica Vincent
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
BASIC_SCIENCE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here